Introduction: The aim of this prospective study was to see whether LD-1227, a quality-controlled marine nutraceuticals shown to protect experimental stress-induced hyppocampal degeneration, could beneficially modulate BDNF, as measured in the serum, in otherwise healthy but work-stressed individuals.
Materials and methods: Forty-eight men and women between the ages of 38 and 62 reporting high-demanding work activity but with an overall positive attitude towards their personal life were recruited. Subjects were divided in two group (24 patients each) and blindly supplemented for 2 month with: a) LD-1227 400mg or b) placebo. A third group of healthy non-stressed subjects was used as well. Blood samples were taken before and after the supplementation period. Unstimulated saliva was collected and tested for amylase while serum levels were used to measure BDNF. State Trait Anxiety Inventory (STAI), Pittsburgh Sleep Quality Index (PSQI) and psychological well-being assessment (PSWB) were measured too. Patients with Val66Met functional polymorphism of BDNF excluded those given their reported association with an impaired release of BDNF.
Results: RESULTS showed that, as compared to healthy, non-stressed individuals, stressed ones has a trend decrease of BDNF and this was significantly increased by LD 12-1227 supplementation and the same inverse phenomenon occurred to salivary amylase (p<0.05). No change was noted in the PSQI score but, either STAI or PSWB tests scored better in LD-1227 supplemented subjects.
Conclusion: The present data suggest that LD-1227 is beneficially affecting neuromodulation and related symptoms during common stressful life conditions and may have the potential as tools in a neuroprotective clinical strategy.
Keywords: LD-1227; Neurogenesis; Neuroprotection; Stress-induced neurodegeneration.
[Study of the stress response: role of anxiety, cortisol and DHEAs].Encephale. 2002 Mar-Apr;28(2):139-46. Encephale. 2002. PMID: 11972140 French.
Relationships between Salivary Melatonin Levels, Quality of Sleep, and Stress in Young Japanese Females.Int J Tryptophan Res. 2013 Oct 10;6(Suppl 1):75-85. doi: 10.4137/IJTR.S11760. eCollection 2013. Int J Tryptophan Res. 2013. PMID: 24174879 Free PMC article.
Association of BDNF Val66Met polymorphism with HPA and SAM axis reactivity to psychological and physical stress.Neuropsychiatr Dis Treat. 2014 Nov 11;10:2123-33. doi: 10.2147/NDT.S68629. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 25419135 Free PMC article.
Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial.Nutr Neurosci. 2015 May;18(4):162-8. doi: 10.1179/1476830513Y.0000000105. Epub 2014 Jan 7. Nutr Neurosci. 2015. PMID: 24621065 Clinical Trial.
Affective alterations in patients with Cushing's syndrome in remission are associated with decreased BDNF and cortisone levels.Eur J Endocrinol. 2017 Feb;176(2):221-231. doi: 10.1530/EJE-16-0779. Eur J Endocrinol. 2017. PMID: 27932530
Cited by 1 article
A 2-year Double-Blind RCT Follow-up Study with Fermented Papaya Preparation (FPP) Modulating Key Markers in Middle-Age Subjects with Clustered Neurodegenerative Disease-Risk Factors.Clin Pharmacol Biopharm. 2017;6:170. doi: 10.4172/2167-065X.1000170. Epub 2017 May 18. Clin Pharmacol Biopharm. 2017. PMID: 31007971 Free PMC article.